 Berwyn, Pennsylvania--Newsfile Corp. - March 23, 2022 - Annovis Bio, Inc. NYSE: ANVS Annovis or the Company, a clinical-stage drug platform company addressing neurodegenerative diseases, today announced the company has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th. Management will present an update on business activities. The pre-recorded presentation can be viewed during the days of the event. Sign... 